Mark Kokoris discovered that he could engineer proteins to do “crazy things,” and this insight fed into his early thoughts about Roche’s newly introduced DNA sequencing technology, called sequencing by expansion (SBX). Mark and his team are the brilliant scientists behind this new technology. Their journey has been one of dedication, experimentation, and creativity, leading to groundbreaking achievement. From an inconclusive, blurry band on a gel during a chemistry experiment to a brighter future full of possibilities, they’ve transformed challenges into innovation. Click here to learn more: https://lnkd.in/df_ExeFg #Genomics #NGS #MakeSpaceWithSBX #RocheSBX
This is amazing👏!!!
Fully agree
Innovation at its finest! 🚀🔬 Congratulations to Mark Kokoris and the entire Roche team for pushing the boundaries of science with sequencing by expansion (SBX). At Timeline International, we celebrate breakthroughs that drive the future of healthcare and life sciences. Exciting times ahead! 👏🔎
Congratulations!
🚀 Impressive leap forward in sequencing technology! At EDGE Biotechnologies, we see SBX as a powerful complement to real-time imaging and quantification. Pairing high-throughput genomics with dynamic, functional bioimaging opens new doors for smarter, faster decisions in R&D. Exciting times ahead for multi-modal innovation! 👏
So excited to be working on this team!
Amazing work!
Congrats!
Merci d’avoir partagé
General Manager Roche Diagnostics Korea | Vice-Chair KMDIA | Author
2wProtein engineering is an interesting research area indeed. It reminds me of my PhD days with Sir Alan Fersht at the MRC Centre for Protein Engineering (now part of MRC Laboratory of Molecular Biology). At the Centre, a lot of pioneering and impactful work on protein folding and antibody humanisation were conducted.